A detailed history of Wells Fargo & Company transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,559 shares of ATNM stock, worth $20,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,559
Previous 14,924 2.45%
Holding current value
$20,964
Previous $110,000 75.45%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.72 - $8.0 $627 - $2,920
-365 Reduced 2.45%
14,559 $27,000
Q2 2024

Aug 13, 2024

BUY
$6.56 - $9.89 $8,245 - $12,431
1,257 Added 9.2%
14,924 $110,000
Q1 2024

May 10, 2024

BUY
$5.0 - $9.2 $6,120 - $11,260
1,224 Added 9.84%
13,667 $107,000
Q4 2023

Feb 09, 2024

BUY
$4.02 - $6.08 $6,978 - $10,554
1,736 Added 16.21%
12,443 $63,000
Q3 2023

Nov 13, 2023

SELL
$5.91 - $7.37 $31,878 - $39,753
-5,394 Reduced 33.5%
10,707 $63,000
Q2 2023

Aug 15, 2023

BUY
$7.15 - $9.39 $75,968 - $99,768
10,625 Added 194.03%
16,101 $119,000
Q1 2023

May 12, 2023

BUY
$8.51 - $14.26 $34 - $57
4 Added 0.07%
5,476 $51,000
Q4 2022

Feb 13, 2023

BUY
$7.05 - $14.41 $2,855 - $5,836
405 Added 7.99%
5,472 $58,000
Q3 2022

Nov 14, 2022

BUY
$4.81 - $8.48 $38 - $67
8 Added 0.16%
5,067 $37,000
Q2 2022

Aug 12, 2022

BUY
$4.71 - $7.11 $108 - $163
23 Added 0.46%
5,059 $25,000
Q1 2022

May 16, 2022

BUY
$4.57 - $6.4 $4 - $6
1 Added 0.02%
5,036 $26,000
Q4 2021

Feb 14, 2022

SELL
$6.01 - $8.8 $2,854 - $4,180
-475 Reduced 8.62%
5,035 $30,000
Q3 2021

Nov 15, 2021

BUY
$5.76 - $9.67 $22,815 - $38,302
3,961 Added 255.71%
5,510 $49,000
Q2 2021

Aug 16, 2021

BUY
$7.01 - $8.63 $1,226 - $1,510
175 Added 12.74%
1,549 $12,000
Q1 2021

May 13, 2021

SELL
$7.62 - $9.79 $121,965 - $156,698
-16,006 Reduced 92.09%
1,374 $11,000
Q4 2020

Feb 09, 2021

BUY
$7.8 - $12.64 $131,125 - $212,491
16,811 Added 2954.48%
17,380 $136,000
Q3 2020

Nov 05, 2020

BUY
$7.26 - $18.0 $4,130 - $10,242
569 New
569 $6,000

Others Institutions Holding ATNM

About Actinium Pharmaceuticals, Inc.


  • Ticker ATNM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,184,700
  • Market Cap $36.3M
  • Description
  • Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...
More about ATNM
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.